Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Cytarabine liposome |
Is a |
True |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing capecitabine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
agent antinéoplasique analogue de la pyrimidine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Capecitabine 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Capecitabine 150 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing tegafur and uracil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tegafur 100 mg and uracil 224 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine 500mg/5mL injection solution (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine 100mg/mL injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine 20mg/mL injection solution 25mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine 1g powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine 100mg/5mL injection solution (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine 100mg/mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine 1g/10mL infusion (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine 100mg powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine 500 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine 500mg/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine 1g/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine 2g/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine 10mg/mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine liposomal 50mg/5mL injection 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Gemcitabine (substance) |
Is a |
True |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluorouracil |
Is a |
False |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Floxuridine (substance) |
Is a |
True |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing cytarabine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine 500mg/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine 1g/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine 2g/vial powder for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine 50 mg/mL suspension for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Azacitidine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Azacitidine 100mg powder for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Azacitidine |
Is a |
True |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Capecitabine (substance) |
Is a |
False |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cytarabine (substance) |
Is a |
True |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tegafur (substance) |
Is a |
False |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Uracil |
Is a |
True |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Decitabine |
Is a |
True |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluorouracil sodium (substance) |
Is a |
False |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluorouracil (18-F) |
Is a |
True |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Gemcitabine hydrochloride (substance) |
Is a |
True |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fluoropyrimidine (substance) |
Is a |
True |
Pyrimidine analog (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|